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Abstract
There has been strong interest in the role of metals in neurodegeneration, and how ageing
may predispose the brain to related diseases such as Alzheimer’s disease. Recent work
has also highlighted a potential interaction between different metal species and various
components of the cytoskeletal network in the brain, which themselves have a reported role
in age-related degenerative disease and other neurological disorders. Neurofilaments are
one such class of intermediate filament protein that have a demonstrated capacity to bind
and utilise cation species. In this study, we investigated the consequences of altering the
neurofilamentous network on metal ion homeostasis by examining neurofilament light (NFL)
gene knockout mice, relative to wildtype control animals, at adulthood (5 months of age) and
advanced age (22 months). Inductively coupled plasma mass spectroscopy demonstrated
that the concentrations of iron (Fe), copper (Cu) and zinc (Zn) varied across brain regions
and peripheral nerve samples. Zn and Fe showed statistically significant interactions
between genotype and age, as well as between genotype and region, and Cu demonstrated
a genotype and region interaction. The most substantial difference between genotypes was
found in Fe in the older animals, where, across many regions examined, there was elevated
Fe in the NFL knockout mice. This data indicates a potential relationship between the neuro-
filamentous cytoskeleton and the processing and/or storage of Fe through ageing.
Introduction
Divalent cation metal species such as zinc, iron and copper have important normal cellular
functions in the nervous system, but may also be involved in pathological processes underlying
neurodegenerative diseases such as Parkinson’s disease (PD), amyotrophic lateral sclerosis
(ALS) and Alzheimer’s disease (AD) [1–3]. Indeed, metal ions have been implicated in many
aspects of the AD cascade [4], including a potentially central role in the aggregation of the two
primary pathological hallmarks of AD, the beta amyloid plaques and neurofibrillary tangles
[5]. In this regard, major proteins implicated in neurodegenerative diseases such as the amy-
loid precursor protein (APP), tau and alpha-synuclein and tau have been shown to be involved
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in metal ion processing and transport [6–8]. Furthermore, metal ions may promote aggrega-
tion of these proteins, contributing to hallmark pathological features [9].
A range of brain proteins have the capacity to bind metal species, with major cell groups,
such as neurons, microglia and astrocytes likely having a spectrum of roles in terms of the stor-
age, metabolism and use of metals. Neurofilaments (NF) are major neuronal proteins and have
putative roles in stabilising axons and regulating axonal diameter [10]. Particular subsets of
neurons demonstrate high levels of the NF ‘triplet’ proteins (NF light (NFL), medium (NFM)
and heavy (NFH) see [10] for review on subunit structure and function), and these correspond
to subpopulations of neurons that are vulnerable to degeneration in AD (cortical pyramidal
neurons), PD (substantia nigra compacta) and ALS (cortical, brainstem and spinal motor neu-
rons) [11–13]. The NFM and NFH subunits have long tail domains that project from the inter-
mediate filament backbone, and which contain glutamate-rich, negatively charged subregions.
In this regard, these protein regions may bind to cations, with accessibility regulated by phos-
phorylation of the tail domains [14].
Neurofilament accumulation in abnormal (dystrophic) neurites associated with beta amy-
loid plaques in the cortex is one of the earliest neuronal changes in the sequence of pathologi-
cal changes leading to AD [13]. The NFL protein is a requisite component for the NF triplet to
form intermediate filaments in neurons. We have also recently demonstrated that the ablation
of NFL in a transgenic mouse model of AD (APPswe/PS1dE9) results in increased beta amy-
loid plaque deposition [15]. These data suggest that the absence of NFs may have an early role
in amyloid misprocessing. Furthermore, substantia nigra neurons in PD also lose NF content
[11], which is associated with the accumulation of iron in these nerve cells [1]. Collectively,
these data suggest that NF triplet-abundant neurons may show changes in these cytoskeletal
proteins as part of the disease process of major neurodegenerative changes, and that such
changes contribute to subsequent pathological alterations potentially with respect to a role in
metal biology within neurons. The following study explores the potential consequences of a
major perturbation of NFs with metal ions, on the background of ageing. We have utilised
mass spectrometry techniques to compare the abundance of metal species implicated in major
neurodegenerative diseases, such as iron (Fe), copper (Cu) and zinc (Zn), in the brains and
peripheral nerves of NFL KO mice as compared to C57BL/6 mice at adulthood (5 months of
age) and following ageing (22 months of age).
Materials and methods
Animals and tissue processing
All animal experimentation was approved by the University of Tasmania Animal Ethics Com-
mittee (Approval Nos A12780 and A15120), in accordance with the Australian code of practice
for the care and use of animals for scientific purposes. NFL KO mice were obtained from the
Nathan Kline Institute (Dr. Mala Rao) and were developed in the laboratory of Dr. Jean-Pierre
Julien [16]. NFL KO mice were maintained as a homozygous knockout colony. NFL KO mice
(on a C57BL/6 background strain) were compared with wild-type (WT) (C57BL/6) mice, the
predominant background strain of the mice [16,17]. Animals were housed in standard condi-
tions (20˚C, 12/12 hours light/dark cycle), with at least 2 animals in each cage with access to
food and water ad libitum. Cohort sizes were as follows, 5 months (n = 11 NFL-KO, n = 7 WT)
and 22 months (n = 6 NFL-KO, n = 7 WT).
Tissue collection and processing
Animals were anaesthetised with 140mg/Kg sodium pentobarbitone (intraperitoneal) and
perfused transcardially with phosphate buffered saline for 3 mins to clear blood from the
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vasculature. Tissue was dissected under microscopic guidance. Briefly, cortical tissue, hippo-
campus, olfactory bulb and cerebellum were collected from each hemisphere and the right
hemisphere used in analysis; brain stem tissue was collected and left and right sciatic nerves
were pooled for analysis. Upon collection, tissue was rapidly snap frozen in liquid nitrogen
and stored at -80˚C until used. Tissue was freeze dried in 96 well plates for 48hrs at -80˚C.
Dried tissue was kept at room temperature until used.
Inductively coupled plasma mass spectroscopy (ICPMS) analysis
Tissue samples were coded and processed for inductively coupled mass spectroscopy analysis
at the Florey Institute of Neuroscience and Mental Health. Tissue samples were lyophilised
and then digested with nitric acid (65% Suprapur, Merck) overnight, followed by heating at
90˚C for 20 min using a heat block. Samples were then removed from the heat block and an
equivalent volume of hydrogen peroxide (30% Aristar, BDH) added to each sample. Once
samples had finished digesting, they were heated for a further 15 mins at 70˚C. Samples were
then diluted with 1% nitric acid diluent. Measurements were made using an Agilent 7700
series ICPMS instrument under routine multi-element operating conditions using a Helium
Reaction Gas Cell. The instrument was calibrated using 0, 5, 10, 50, 100 and 500 ppb of certi-
fied multi-element ICPMS standard calibration solutions (ICP-MS-CAL2-1, ICP-MS-CAL-3
and ICP-MS-CAL-4, Accustandard) for a range of elements, and we also utilised a certified
internal standard solution containing 200 ppb of Yttrium (Y89) as a control (ICP-MS-IS-
MIX1-1, Accustandard).
Statistical analysis
Mixed effects models were fitted using the lme4 package in R. Random intercepts for each sub-
ject were specified in order to account for non-independence between brain regions within
animals. Model assumptions were checked using standard graphical techniques, and a loge-
transformation applied to Zn and Fe variables to improve normality of residuals and homoge-
neity of error variance. One substantial outlier was removed from Cu. Type III F statistics
and 95% Confidence Intervals for the estimated marginal means were computed using the
Kenward-Roger approximation for degrees of freedom. A measure of standardized effect
size, Cohen’s f2 was calculated for the effect of genotype for each metal using the formula,






where R2AB is the coefficient of determination for the full model, and R
2
A is the coeffi-
cient of determination for a reduced model that does not contain the term of interest. The
method of Nakagawa and Schielzeth [18] for computing a marginal pseudo-R2 for mixed mod-
els was used to calculate R2 coefficients.
Results and discussion
Broadly, Fe content was increased in NFL KO and WT mice with ageing across most nervous
system samples, with the exception of the olfactory bulb. In this regard, there was a more sub-
stantial ageing-related increase in Fe content in NFL KO mice relative WT animals, particu-
larly in the cerebellum, cortex, hippocampus and sciatic nerve (Fig 1). For many CNS regions,
there was higher content of Zn in older NFL KO mice relative to WT mice. In addition, the sci-
atic nerve of NFL KO mice showed higher levels of Zn that WT mice at both 5 and 22 months
of age. No consistent pattern of difference between NFL KO and WT mice was observed for
Cu.
Genotype x age (Fig 1) and genotype x region (Fig 2) interactions were investigated for
each metal cation in a model which accounted for region x age interactions and intra-class
Metals and neurofilaments
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Fig 1. Metal composition at different ages. Fe, Zn, and Cu in sampled brain regions at 5mo and 22mo, for WT and
NFL-KO mice. Error-bars show estimated marginal means (over all regions) and 95% CI, showing the strength and
direction of these patterns of metal accumulation. There were significant genotype x age interactions for Zn and Fe
(Zn: F(1, 27) = 9, p = .005; Fe: F(1, 27) = 11, p = .002).
https://doi.org/10.1371/journal.pone.0224169.g001
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Fig 2. Metal variability in different brain regions. Estimated marginal means (and 95% CI) show patterns of Fe, Zn,
and Cu composition in different brain regions for the two genotypes (WT and NFL-KO; averaged over 5mo and 22mo
animals). There were significant genotype x region interactions for Zn, Fe and Cu (Zn: F(5, 140) = 8, p< .001; Fe:
F(5, 140) = 3, p = .021; F(5, 139) = 4, p = .002).
https://doi.org/10.1371/journal.pone.0224169.g002
Metals and neurofilaments
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correlation within region for each animal. For Zn and Fe, there were significant genotype x
age interactions (Zn: F(1, 27) = 9, p = .005; Fe: F(1, 27) = 11, p = .002) and genotype x region
interactions (Zn: F(5, 140) = 8, p< .001; Fe: F(5, 140) = 3, p = .021). For Cu, only the genotype x
region interaction was significant (F(5, 139) = 4, p = .002).
The standardized effect of genotype on Cu accumulation in tissues was small (f 2Cu ¼ 0:09),
however the standardized effect of genotype on Zn and Fe accumulation in tissues was moder-
ate (f 2logðZnÞ ¼ 0:27; f
2
logðFeÞ ¼ 0:25).
The current study shows that there were differences in Cu, Zn and Fe concentrations across
regions of the nervous system. For example, Fe was relatively abundant in the brain stem, with
lower levels in the olfactory bulb. The olfactory bulb also showed relatively lower levels of both
Zn and Cu. The sciatic nerve demonstrated very low levels of Cu, relative to Fe and Zn.
One of the most prominent differences between NFL KO and WT mice was found for Fe,
especially for older animals. Moderate genotype differences were also detected for Zn, with the
most pronounced difference was present for sciatic nerve. In many regions, Zn abundance did
not decrease in the NFL KO mice over ageing relative to the WT mice. Consistent patterns of
genotype difference for Cu were not observed.
These studies were motivated by our previous observations that APPswe/PS1dE9 mice on a
NFL KO background demonstrated higher amyloid plaque deposition [15]. In this regard, we
were interested in potential differences in brain content of Fe, Zn and Cu, metals implicated in
beta amyloid processing and aggregation into plaques, that may be related to the absence of
NFL and a complete neurofilamentous network [16,17]. The relatively increased levels of Fe
across most brain regions of aged NFL KO mice, as well as relatively maintained levels of Zn,
may be particularly significant in the context of contributing to an environment that drives
Alzheimer’s disease pathology. We have previously shown that there are substantial changes in
NF localisation in the hippocampus during ageing, that abnormal accumulation of NFs in dys-
trophic neurites surrounding plaques is the earliest neuronal pathology of AD and that tau
pathology replaces the normal NF network in neurofibrillary tangles and dystrophic neurites
[13]. Changes to the integrity of neurofilamentous networks during ageing could possibly also
follow decades of wear and tear on axons, and may possibly result in increased levels of Fe in
the extracellular environment, which then impact on multiple aspects of AD pathogenesis. The
translation of APP, which is the parent protein to the Abeta of extracellular plaques in the AD
brain, is regulated by an iron response element in the APP mRNA [19,20] and the secretase
cleavage of APP to form Abeta is also regulated by iron. Furthermore, the aggregation and
oligomerization of Abeta is potentiated by iron, which is also likely to contribute to Abeta-
mediated oxidative damage [21–26]. Similarly, iron can induce the aggregation of tau [27] and
the association of redox active iron with tau and neurofibrillary tangles may contribute to oxi-
dative stress [28]. In addition, a loss of NFs in substantia nigra neurons in the early stages of
PD [11] may also be linked to the accumulation of Fe in these cells [1].
The current data supports the existence of a relationship between NF protein levels and
metal ions in the brain, potentially relating to the regulation and/or storage of metals. Cations
may also have direct roles in the organisation of neurofilamentous networks. Iron deficiency,
for example, can impact neurofilament phosphorylation during development [29]. Copper and
iron may also have a role in catechol-mediated cross-linking of neurofilament proteins [30],
and copper and zinc have the capacity to directly bind to the NFH subunit [31]. Divalent ions
such as Ca, Mg and Zn have been shown to act as cross-linkers between NFs, influencing the
gelation and viscoelastic properties of neurofilamentous networks [32,33]. Finally, atomic force
microscopy experiments support the cross-linking role of divalent cations, particularly in mod-
erating the spacing and mechanical properties of phosphorylated NF side-arm structures [34].
Metals and neurofilaments
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Conclusions
Cumulatively, these data show that the absence of NF-L, and a neurofilamentous network per-
turbs the processing and/or storage of Fe through ageing, leading to higher levels of this metal
in the brain and sciatic nerve. Biomarker studies indicate a progressive perturbation of NFs
with ageing and neuroaxonal degeneration involving these proteins across a wide range of
neurodegenerative conditions [35]. Hence, alterations in neurofilaments during brain ageing
may, thus, create an intracellular or extracellular environment of excess Fe, which could con-
tribute to risk of either neuronal degeneration or protein accumulation in neurodegenerative
conditions such as Alzheimer’s and/or Parkinson’s disease.
Acknowledgments
This work was funded by the J.O. and J.R. Wicking Trust (Equity Trustees). The Florey Insti-
tute of Neuroscience and Mental Health acknowledge the strong support from the Victorian
Government and in particular the funding from the Operational Infrastructure Support Grant.
Author Contributions
Conceptualization: James C. Vickers, Anna E. King, Paul A. Adlard.
Data curation: Aidan D. Bindoff, Paul A. Adlard.
Formal analysis: James C. Vickers, Anna E. King, Graeme H. McCormack, Aidan D. Bindoff,
Paul A. Adlard.
Funding acquisition: James C. Vickers, Paul A. Adlard.
Investigation: James C. Vickers, Graeme H. McCormack, Aidan D. Bindoff, Paul A. Adlard.
Methodology: Graeme H. McCormack, Aidan D. Bindoff, Paul A. Adlard.
Project administration: James C. Vickers, Graeme H. McCormack.
Resources: James C. Vickers, Paul A. Adlard.
Validation: James C. Vickers, Paul A. Adlard.
Visualization: James C. Vickers, Aidan D. Bindoff.
Writing – original draft: James C. Vickers, Anna E. King, Graeme H. McCormack, Aidan D.
Bindoff, Paul A. Adlard.
Writing – review & editing: James C. Vickers.
References
1. Belaidi AA, Bush AI. Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for
therapeutics. J Neurochem. 2016; 139:179–219.
2. Portbury AD, Adlard PA. Zinc signal in brain diseases. Int J Mol Sci. 2017; 18, E2506. https://doi.org/
10.3390/ijms18122506 PMID: 29168792
3. Giampietro R, Spinelli F, Contino M, Colabufo NA. The pivotal role of copper in neurodegeneration: A
new strategy for the therapy of neurodegenerative disorders. Mol Pharm. 2018; 15, 808–820. https://
doi.org/10.1021/acs.molpharmaceut.7b00841 PMID: 29323501
4. Adlard PA, Bush AI. (2006) Metals and Alzheimer’s disease. J Alzheimers Dis. 2006; 10: 145–163.
PMID: 17119284
5. Cristo´vão JS, Santos R, Gomes CM. Metals and neuronal metal binding proteins implicated in Alzhei-
mer’s disease. Oxid Med Cell Longev. 2016; 2016: 9812178. https://doi.org/10.1155/2016/9812178
PMID: 26881049
Metals and neurofilaments
PLOS ONE | https://doi.org/10.1371/journal.pone.0224169 October 23, 2019 7 / 9
6. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, et al. Iron-export ferroxidase activity of
β-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell. 2010; 142: 857–867.
https://doi.org/10.1016/j.cell.2010.08.014 PMID: 20817278
7. Lei P, Ayton S, Appukuttan AT, Moon S, Duce JA, Volitakis I, et al. Lithium suppression of tau induces
brain iron accumulation and neurodegeneration. Mol Psychiatry. 2017; 22: 396–406. https://doi.org/10.
1038/mp.2016.96 PMID: 27400857
8. Joppe K, Roser A-E, Maass F, Lingor P. The contribution of iron to protein aggregation disorders in the
central nervous system. Frontiers Neurosci. 2019; 13: 15.10.
9. Ortega R, Carmona A, Roudeau S, Perrin L, Ducic T, Carboni E, et al. Alpha-Synuclein over-expression
induces increased iron accumulation and redistribution in iron-exposed neurons. Mol Neurobiol. 2016;
53: 1925–1934. https://doi.org/10.1007/s12035-015-9146-x PMID: 25833099
10. Kirkcaldie MTK, Dwyer ST. The third wave: Intermediate filaments in the maturing nervous system. Mol
Cell Neurosci. 2017; 84: 68–76. https://doi.org/10.1016/j.mcn.2017.05.010 PMID: 28554564
11. Gai WP, Vickers JC, Blumbergs PC, Blessing WW. Loss of non-phosphorylated neurofilament immuno-
reactivity with preservation of tyrosine hydroxylase in surviving substantia nigra neurons in Parkinson’s
disease. J Neurol Neurosurg Psychiat. 1994; 57: 1039–1046. https://doi.org/10.1136/jnnp.57.9.1039
PMID: 7916375
12. Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, McCormack GH et al. Axonopathy and
cytoskeletal disruption in degenerative diseases of the central nervous system. Brain Res Bull. 2009;
80: 217–223. https://doi.org/10.1016/j.brainresbull.2009.08.004 PMID: 19683034
13. Vickers JC, Kirkcaldie MTK, Phipps AJ, King AE. Alterations in neurofilaments and the transformation
of the cytoskeleton in axons may provide insight into the aberrant neuronal changes of Alzheimer’s dis-
ease. Brain Res Bull. 2016; 126: 324–333. https://doi.org/10.1016/j.brainresbull.2016.07.012 PMID:
27475416
14. Lefebvre S, Mushynski ME. Characterization of the cation-binding properties of porcine neurofilaments.
Biochemistry. 1988; 27: 8503–8508. https://doi.org/10.1021/bi00422a031 PMID: 3149507
15. Fernandez-Martos CM, King AE, Atkinson RA, Woodhouse A, Vickers JC. Neurofilament light gene
deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic
model of Alzheimer’s disease. Neurobiol Aging. 2015; 36: 2757–2767. https://doi.org/10.1016/j.
neurobiolaging.2015.07.003 PMID: 26344875
16. Zhu Q, Couillard-Despre´s S, Julien JP. Delayed maturation of regenerating myelinated axons in mice
lacking neurofilaments. Exp Neurol. 1997; 148: 299–316. https://doi.org/10.1006/exnr.1997.6654
PMID: 9398473
17. Liu Y, Staal JA, Canty AJ, Kirkcaldie M, King AE, Bibari O. et al. Cytoskeletal changes during develop-
ment and aging in the cortex of neurofilament light protein knockout mice. J Comp Neurol. 2013; 521:
1817–1827. https://doi.org/10.1002/cne.23261 PMID: 23172043
18. Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear
mixed-effects models. Methods Ecol Evolution. 2013; 4: 133–142.
19. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan, Potter H et al. Translation of the alzheimer amyloid
precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences. J
Biol Chem. 1999; 274: 6421–6431. https://doi.org/10.1074/jbc.274.10.6421 PMID: 10037734
20. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H et al. An iron-responsive element
type II in the 5’-untranslated region of the Alzheimer’s amyloid precursor protein transcript. J Biol Chem.
2002; 277: 45518–45528. https://doi.org/10.1074/jbc.M207435200 PMID: 12198135
21. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR et al. Cu(II) potentiation
of alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal
reduction. J Biol Chem. 1999; 274: 37111–37116. https://doi.org/10.1074/jbc.274.52.37111 PMID:
10601271
22. Huang X, Atwood CS, Moir RD, Hartshorn MA, Tanzi RE, Bush AI. Trace metal contamination initiates
the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Abeta peptides. J Biol
Inorg Chem. 2004; 9: 954–960. https://doi.org/10.1007/s00775-004-0602-8 PMID: 15578276
23. Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC et al. Iron promotes the toxicity of amy-
loid beta peptide by impeding its ordered aggregation. J Biol Chem. 2011; 286: 4248–4256.
24. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER et al. Aluminum, iron, and zinc
ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem. 1993;
61: 1171–1174. https://doi.org/10.1111/j.1471-4159.1993.tb03639.x PMID: 8360682
25. Schubert D, Chevion M. The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun. 1995;
216: 702–707. https://doi.org/10.1006/bbrc.1995.2678 PMID: 7488167
Metals and neurofilaments
PLOS ONE | https://doi.org/10.1371/journal.pone.0224169 October 23, 2019 8 / 9
26. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disor-
ders. Mol Cell Biochem. 2010; 345: 91–104. https://doi.org/10.1007/s11010-010-0563-x PMID:
20730621
27. Yamamoto A, Shin RA, Hasegawa K, Naiki H, Sato H, Yoshimasu F et al. Iron (III) induces aggregation
of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the for-
mation of neurofibrillary tangles of Alzheimer’s disease. J Neurochem. 2002; 82: 1137–1147. https://
doi.org/10.1046/j.1471-4159.2002.t01-1-01061.x PMID: 12358761
28. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofi-
brillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol. 1992; 31: 286–
292. https://doi.org/10.1002/ana.410310310 PMID: 1637136
29. Lee DL, Strathmann FG, Gelein R, Walton J, Mayer-Pro¨schel M. Iron deficiency disrupts axon matura-
tion of the developing auditory nerve. J Neurosci. 2012; 32: 5010–5015. https://doi.org/10.1523/
JNEUROSCI.0526-12.2012 PMID: 22492056
30. Montine TJ, Farris DB, Graham DG. Covalent crosslinking of neurofilament proteins by oxidized cate-
chols as a potential mechanism of Lewy body formation. J Neuropathol Exp Neurol. 1995; 54: 311–
319. https://doi.org/10.1097/00005072-199505000-00004 PMID: 7745430
31. Pierson KB, Evenson MA. 200 Kd neurofilament protein binds Al, Cu and Zn. Biochem Biophys Res
Commun. 1988; 152: 598–604. https://doi.org/10.1016/s0006-291x(88)80080-9 PMID: 3130052
32. Yao NY, Broedersz CP, Lin YC, Kasza KE, Mackintosh FC, Weitz DA. Elasticity in ionically cross-linked
neurofilament networks. Biophys J. 2010; 98: 2147–2153. https://doi.org/10.1016/j.bpj.2010.01.062
PMID: 20483322
33. Pregent S, Lichtenstein A, Avinery R, Laser-Azogui A, Patolsky F, Beck R. Probing the interactions of
intrinsically disordered proteins using nanoparticle tags. Nano Lett. 2015; 15: 3080–3087. https://doi.
org/10.1021/acs.nanolett.5b00073 PMID: 25822629
34. Lei R, Lee JP, Francis MB, Kumar S. Structural regulation of a neurofilament-inspired intrinsically disor-
dered protein brush by multisite phosphorylation. Biochemistry. 2018; 57: 4019–4028. https://doi.org/
10.1021/acs.biochem.8b00007 PMID: 29557644
35. Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group. Diagnostic
Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-
analysis. JAMA Neurol. 2019 https://doi.org/10.1001/jamaneurol.2019.1534 PMID: 31206160
Metals and neurofilaments
PLOS ONE | https://doi.org/10.1371/journal.pone.0224169 October 23, 2019 9 / 9
